Biologically active complement (C5)-derived peptides and their relevance to disease
Open Access
- 31 December 1984
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 1 (3) , 199-225
- https://doi.org/10.1016/s1040-8428(84)80012-8
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Chemotactic activity of C5ades Arg: Evidence of a requirement for an anionic peptide ‘helper factor’ and inhibition by a cationic protein in serum from patients with systemic lupus erythematosusMolecular Immunology, 1980
- Isolation and characterization of an acidic chemotactic factor from complement-activated human serumClinical Immunology and Immunopathology, 1980
- Isolation by hydrophobic chromatography of the chemotactic factor inactivators from human serumClinical Immunology and Immunopathology, 1979
- Complement and Leukocyte-Mediated Pulmonary Dysfunction in HemodialysisNew England Journal of Medicine, 1977
- Role of microtubule assembly in lysosomal enzyme secretion from human polymorphonuclear leukocytes. A reevaluation.The Journal of cell biology, 1977
- Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.Journal of Clinical Investigation, 1976
- CHEMOTAXIS AND HAEMOSTASISBritish Journal of Haematology, 1975
- Circular dichroism of C5a anaphylatoxin of porcine complementBiochemical and Biophysical Research Communications, 1974
- Studies on ChemotaxisInternational Archives of Allergy and Immunology, 1969